Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

446 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence.
Laukhtina E, Abufaraj M, Al-Ani A, Ali MR, Mori K, Moschini M, Quhal F, Sari Motlagh R, Pradere B, Schuettfort VM, Mostafaei H, Katayama S, Grossmann NC, Fajkovic H, Soria F, Enikeev D, Shariat SF; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group. Laukhtina E, et al. Among authors: pradere b. Eur Urol Focus. 2022 Mar;8(2):447-456. doi: 10.1016/j.euf.2021.03.016. Epub 2021 Mar 21. Eur Urol Focus. 2022. PMID: 33762203 Free article. Review.
Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines Panel.
Köves B, Cai T, Veeratterapillay R, Pickard R, Seisen T, Lam TB, Yuan CY, Bruyere F, Wagenlehner F, Bartoletti R, Geerlings SE, Pilatz A, Pradere B, Hofmann F, Bonkat G, Wullt B. Köves B, et al. Among authors: pradere b. Eur Urol. 2017 Dec;72(6):865-868. doi: 10.1016/j.eururo.2017.07.014. Epub 2017 Jul 25. Eur Urol. 2017. PMID: 28754533 Review.
Update on Strategies to Reduce Infectious Complications After Prostate Biopsy.
Pilatz A, Veeratterapillay R, Köves B, Cai T, Bartoletti R, Wagenlehner F, Bruyère F, Geerlings S, Bonkat G, Pradere B. Pilatz A, et al. Among authors: pradere b. Eur Urol Focus. 2019 Jan;5(1):20-28. doi: 10.1016/j.euf.2018.11.009. Epub 2018 Nov 30. Eur Urol Focus. 2019. PMID: 30503175 Review.
Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis.
Mori K, Miura N, Mostafaei H, Quhal F, Sari Motlagh R, Pradere B, Kimura S, Kimura T, Egawa S, Briganti A, Karakiewicz PI, Shariat SF. Mori K, et al. Among authors: pradere b. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):539-548. doi: 10.1038/s41391-020-0222-6. Epub 2020 Mar 9. Prostate Cancer Prostatic Dis. 2020. PMID: 32152435
Catalog of exogenous risk factors for bladder carcinogenesis.
Jahrreiss V, Pradere B, Laukhtina E, Mori K, Shariat SF. Jahrreiss V, et al. Among authors: pradere b. Curr Opin Urol. 2020 May;30(3):449-456. doi: 10.1097/MOU.0000000000000753. Curr Opin Urol. 2020. PMID: 32235283 Review.
446 results